Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY

[1]  L. Køber,et al.  Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment , 2019, PloS one.

[2]  T. Ohashi [Current status and future prospect of enzyme replacement therapy for Fabry disease]. , 2019, Rinsho shinkeigaku = Clinical neurology.

[3]  J. Moon,et al.  Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  C. Wanner,et al.  Characterization of vertigo and hearing loss in patients with Fabry disease , 2018, Orphanet Journal of Rare Diseases.

[5]  N. Sousa,et al.  Inner ear involvement in Fabry disease: Clinical and audiometric evaluation of a large cohort of patients followed in a reference centre. , 2018, European journal of medical genetics.

[6]  C. Eng,et al.  Fabry disease revisited: Management and treatment recommendations for adult patients. , 2018, Molecular genetics and metabolism.

[7]  C. Wanner,et al.  Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease , 2017, PloS one.

[8]  R. Reisin,et al.  Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease , 2017, Audiology research.

[9]  C. Wanner,et al.  Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. , 2017, Journal of the American Society of Nephrology : JASN.

[10]  D. Lockhart,et al.  The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat , 2016, Genetics in Medicine.

[11]  G. Andria,et al.  Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Richard B. Thompson,et al.  Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment , 2015, Heart Failure Reviews.

[13]  W. Dreschler,et al.  Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy , 2015, Journal of Inherited Metabolic Disease.

[14]  J. England,et al.  Fabry's disease , 2014, Journal of the Neurological Sciences.

[15]  Luigi Ferrucci,et al.  Hearing loss prevalence in the United States. , 2011, Archives of internal medicine.

[16]  P. Herman,et al.  Atteintes ORL de la maladie de Fabry : à propos de 25 observations , 2011 .

[17]  G. Gates,et al.  Challenges and Opportunities in Presbycusis , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  C. Eng,et al.  Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry , 2008, Pediatric Research.

[19]  D. Straumann,et al.  Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy , 2007, Journal of Neurology.

[20]  J M Dambrosia,et al.  Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. , 2006, Brain : a journal of neurology.

[21]  S. Brodie,et al.  Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement , 2006, Genetics in Medicine.

[22]  P. Avan,et al.  La maladie de Fabry : l'atteinte vasculaire multi-organe pourrait également intéresser la cochlée , 2006 .

[23]  A. Roscher,et al.  Disease manifestations and X inactivation in heterozygous females with Fabry disease , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[24]  P. Avan,et al.  Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients , 2002, BMC Medical Genetics.

[25]  R B D'Agostino,et al.  Central auditory dysfunction, cognitive dysfunction, and dementia in older people. , 1996, Archives of otolaryngology--head & neck surgery.